Janus Henderson Capital Funds plc - Global Life Sciences Fund Class A2 USD

Register to Unlock Ratings
Performance History31/05/2021
Growth of 1,000 (GBP) Advanced Graph
Janus Henderson Capital Funds plc - Global Life Sciences Fund Class A2 USD
Fund10.18.322.219.6-4.0
+/-Cat0.25.75.12.1-5.7
+/-B’mrk0.7-0.53.79.6-6.6
 
Key Stats
NAV
15/06/2021
 USD 48.84
Day Change -0.34%
Morningstar Category™ Sector Equity Healthcare
ISIN IE0009355771
Fund Size (Mil)
15/06/2021
 USD 4412.91
Share Class Size (Mil)
15/06/2021
 USD 742.08
Max Initial Charge 5.00%
Ongoing Charge
12/02/2021
  2.37%
Investment Objective: Janus Henderson Capital Funds plc - Global Life Sciences Fund Class A2 USD
The Fund’s investment objective is long-term growth of capital. It pursues its objective by investing at least 80% of its net asset value in equities (also known as company shares) located anywhere in the world and selected for their growth potential. The Fund will invest at least 80% of its net asset value in companies that the relevant Sub-Investment Adviser believes have a life sciences orientation. Generally speaking, the “life sciences” relate to maintaining or improving quality of life. Thus, companies with a “life sciences orientation” include companies engaged in research, development, production or distribution of products or services related to health and personal care, medicine or pharmaceuticals. Such companies may also include companies that the relevant Sub-Investment Adviser believes have growth potential mainly as a result of particular products, technology, patents or other market advantages in the life sciences.
Returns
Trailing Returns (GBP)15/06/2021
YTD-0.98
3 Years Annualised12.01
5 Years Annualised13.59
10 Years Annualised17.37
12 Month Yield 0.00
Management
Manager Name
Start Date
Andrew Acker
01/05/2007
Ethan Lovell
31/12/2015
Inception Date
31/03/2000
Advertisement
Category Benchmark
Fund BenchmarkMorningstar Benchmark
MSCI World/Health Care NR USDMSCI World/Health Care NR USD
Target Market
Role In Portfolio
Standalone / CoreNot Specific
ComponentNot Specific
OtherNot Specific
Primary Objective
PreservationNot Specific
GrowthYes
IncomeNot Specific
HedgingNot Specific
OtherNot Specific
Portfolio Profile for  Janus Henderson Capital Funds plc - Global Life Sciences Fund Class A2 USD31/05/2021
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stock97.080.0097.08
Bond0.000.000.00
Property0.000.000.00
Cash17.9417.580.36
Other2.560.002.56
Top 5 Regions%
United States80.98
Europe - ex Euro7.34
United Kingdom5.59
Eurozone2.17
Japan1.85
Top 5 Sectors%
Healthcare99.75
Basic Materials0.16
Financial Services0.09
Top 5 HoldingsSector%
AstraZeneca PLCHealthcareHealthcare4.37
UnitedHealth Group IncHealthcareHealthcare4.20
AbbVie IncHealthcareHealthcare2.97
Roche Holding AGHealthcareHealthcare2.88
Merck & Co IncHealthcareHealthcare2.76
Janus Henderson Capital Funds plc - Global Life Sciences Fund Class A2 USD

Related

In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(https://www.morningstar.com/research/signature)

Audience Confirmation


By clicking 'accept' I acknowledge that this website uses cookies and other technologies to tailor my experience and understand how I and other visitors use our site. See 'Cookie Consent' for more detail.

  • Other Morningstar Websites
© Copyright 2021 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Cookies       Modern Slavery Statement